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Abstract
Background: The effects of blood transfusion on renal microcirculation during sepsis are unknown. This study
aimed to investigate the effect of blood transfusion on renal microvascular oxygenation and renal function during
sepsis-induced acute kidney injury.
Methods: Twenty-seven Wistar albino rats were randomized into four groups: a sham group (n = 6), a lipopolysaccharide
(LPS) group (n = 7), a LPS group that received fluid resuscitation (n = 7), and a LPS group that received blood transfusion
(n = 7). The mean arterial blood pressure, renal blood flow, and renal microvascular oxygenation within the kidney cortex
were recorded. Acute kidney injury was assessed using the serum creatinine levels, metabolic cost, and histopathological
lesions. Nitrosative stress (expression of endothelial (eNOS) and inducible nitric oxide synthase (iNOS)) within the kidney
was assessed by immunohistochemistry. Hemoglobin levels, pH, serum lactate levels, and liver enzymes were measured.
Results: Fluid resuscitation and blood transfusion both significantly improved the mean arterial pressure and renal
blood flow after LPS infusion. Renal microvascular oxygenation, serum creatinine levels, and tubular damage
significantly improved in the LPS group that received blood transfusion compared to the group that received
fluids. Moreover, the renal expression of eNOS was markedly suppressed under endotoxin challenge. Blood
transfusion, but not fluid resuscitation, was able to restore the renal expression of eNOS. However, there were no
significant differences in lactic acidosis or liver function between the two groups.
Conclusions: Blood transfusion significantly improved renal function in endotoxemic rats. The specific beneficial
effect of blood transfusion on the kidney could have been mediated in part by the improvements in renal
microvascular oxygenation and sepsis-induced endothelial dysfunction via the restoration of eNOS expression
within the kidney.
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Background
Acute kidney injury (AKI) is a serious complication of
sepsis in the intensive care setting that is associated with
increases in the likelihood of death, prolonged hospital
stays, and increased costs of care [1, 2]. The balance be-
tween renal microcirculatory oxygen delivery and cellu-
lar oxygen consumption is significantly disturbed during
sepsis. Indeed, renal microvascular oxygenation is highly
sensitive to endotoxemia, and renal hypoxia plays a
crucial role in the pathogenesis of sepsis-induced AKI
[3]. Moreover, the negative effects of anemia in critically
ill patients with AKI have been previously described, and
a hemoglobin concentration below 9 g/dl upon intensive
care unit admission has been found to be an independ-
ent risk factor for mortality [4]. Previous studies that
have measured renal microcirculatory oxygen pressure
in experimental models of shock have consistently dem-
onstrated that while fluid resuscitation (FR) is able to
correct systemic hemodynamic variables it is unable to
correct renal microcirculatory dysfunction [5, 6]. Based
on this inability of fluids to improve oxygen delivery to
the renal microcirculation, we hypothesized that the
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transfusion of oxygen-carrying red blood cells would im-
prove sepsis-induced hypoxia. Two clinical studies have
examined the ability of blood transfusion (BT) to correct
the perfusion and oxygenation of the microcirculation in
septic shock patients [7, 8]. These studies demonstrated
that the microcirculation is globally unaltered by BT in
septic patients; however, patients with altered capillary
perfusion at baseline improve after BT [7]. To date, no
study has focused on the effect of BT on sepsis-induced
AKI.
The purpose of this study was to investigate the effect
of BT on renal microvascular oxygenation and renal out-
come (e.g., renal function and structural changes) during
sepsis-induced AKI. We used an endotoxemic model to
examine the questions: (1) whether BT can correct
sepsis-induced renal microcirculatory hypoxemia; (2)
whether BT is superior to FR in terms of restoring renal
hypoxemia during sepsis; and (3) whether an improve-
ment in renal hypoxemia translates into a better renal
outcome. We compared the effects of FR involving a
crystalloid solution and BT on renal hemodynamic pa-
rameters, renal oxygenation, renal function, renal dam-
age, and nitrosative stress to investigate the extent to
which improvements could be achieved by the adminis-
tration of an oxygen-carrying resuscitation fluid.
Methods
Animals
The experiments were performed on Wistar albino rats
(Harlan Netherlands BV, Horst, The Netherlands) with a
mean body weight of 325 ± 19 g.
Experimental protocol
Surgical preparation and blood gas measurements are
detailed in Additional file 1.
The rats were randomized into four groups: (1) a sham
operation group (control, n = 6), (2) a lipopolysaccharide
(LPS) group (n = 7), (3) a LPS group with fluid resuscita-
tion and a targeted mean arterial pressure (MAP) of 80–
90 mmHg (LPS + FR, n = 7), and (4) a LPS group with
blood transfusion and a targeted MAP of 80–90 mmHg
(LPS + BT, n = 7). In the septic groups, a 30-min infusion
of LPS (10 mg/kg; serotype 0127:B8; Sigma, The
Netherlands) was given to induce septic shock. Fluid re-
suscitation was performed with a crystalloid solution
(Ringer’s lactate; Baxter). Fluid resuscitation (median
4.64 ml, interquartile range 3–7 ml) and blood transfu-
sion (median 4.19 ml, interquartile range 3–5.5 ml) (p =
0.2) were initiated 120 min after the end of LPS infusion
and ended 15 min later. The experiment was ended 180
min after the end of LPS infusion or at the correspond-
ing time point for the control group (Fig. 1). Of note, es-
timated blood volume in Wistar rats with a mean body
weight of 325 g is 20.3 ml (from the equation of Lee and
Blaufox [9]). Thus, 4.64 ml represents 22.8% of volemia
and 4.19 ml represents 20.6% of volemia.
Blood transfusion
Blood samples were obtained from donor inbred Wistar
albino rats. The donor rats were anesthetized and mech-
anically ventilated. The right femoral artery was cannu-
lated to draw blood samples. The blood samples were
mixed with a standard citrate-phosphate-dextrose-ad-
enosine anticoagulant solution at a 4:1 volume ratio.
Allogeneic BTs from these donor rats were administered
to the study group through the right jugular vein with a
targeted MAP between 80 and 90 mmHg.
Measurement of renal microvascular oxygenation
The renal microvascular partial pressure of oxygen
(CμPO2) within the kidney cortex was measured by
oxygen-dependent quenching of palladium-porphyrin
phosphorescence using a phosphorimeter with a gated
photomultiplier as previously described [10, 11]. Briefly,
intravenously infused palladium-porphyrin binds to al-
bumin. If excited by a flash of light (wavelength 530
nm), the palladium-porphyrin albumin complex emits
phosphorescence (wavelength >700 nm). Depending on
the oxygen concentration, the phosphorescence intensity
decreases, and the relationship between the measured
Fig. 1 Experimental protocol. Time frame of the study. BT blood transfusion, FR fluid resuscitation, LPS lipopolysaccharide, MAP mean arterial pressure
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decay time and the partial pressure of oxygen (PO2) can
be estimated using the Stern-Volmer relation [11].
Measurement of renal blood flow
During the experimental procedure, the renal vessels
were carefully separated with preservation of the nerves
and adrenal gland. A perivascular ultrasonic transient
time flow probe was placed around the left renal artery
(type 0.7 RB; Transonic Systems Inc., Ithaca, NY, USA)
and connected to a flow meter (T206; Transonic Sys-
tems Inc.) to continuously measure the renal blood flow.
Calculation of derivatives of oxygenation parameters and
renal vascular resistance
Renal oxygen delivery was calculated as follows: DO2ren
(ml/min) = renal blood flow × arterial oxygen content
(1.31 × hemoglobin × arterial oxygen saturation) + (0.003 ×
arterial pressure of oxygen). Renal oxygen consumption
was calculated as follows: VO2ren (ml/min/g) = renal blood
flow × (CaO2 – CvO2), where renal venous oxygen content
(CvO2) is calculated as (1.31 × hemoglobin × renal venous
oxygen saturation) + (0.003 × renal venous partial pressure
of oxygen (rvPO2)) [12]. An estimation of the renal vas-
cular resistance was made as follows: renal vascular re-
sistance (dynes·sec·cm–5) = (MAP/renal blood flow) ×
100 [13].
Creatinine clearance
Creatinine clearance (ml/min) was assessed as an index
of the glomerular filtration rate. Clearance was calcu-
lated using the following formula: Creatinine clearance
= (Ucrea × V)/Pcrea, where Ucrea was the concentration of
creatinine in urine, V was the urine volume per unit
time, and Pcrea was the concentration of creatinine in
plasma.
Renal energy efficiency for sodium transport: metabolic
cost
The renal energy efficiency for sodium transport (VO2/
TNa) was assessed using a ratio that was calculated from
the total amount of VO2 over the total amount of so-
dium reabsorbed (TNa, mmol/min) according to the fol-
low equation: ((Ucrea × V)/Pcrea × PNa) – UNa × V, where
Ucrea is the concentration of creatinine in the urine, V
the urine volume per unit time, Pcrea is the concentra-
tion of creatinine in the plasma, PNa is the concentra-
tion of sodium in plasma, and UNa is the concentration
of sodium in the urine [14].
Histological analysis
Four percent formalin-fixed, paraffin-embedded renal
tissue sections (4 μm) were stained with periodic acid-
Schiff + hematoxylin-eosin reagent. Histological changes
in the cortex were assessed via quantitative
measurements of tissue damage. The histological criteria
for renal damage were tubular epithelial swelling, brush
border loss, vacuolar degeneration, necrotic tubules, lu-
minal cast formation, and invagination. The degree of
kidney damage was estimated at 400× magnification
using 10 randomly selected fields from each animal ac-
cording to the following criteria: 0, normal; 1, areas of
damage <10% of the tubules; 2, damage involving 10% to
25% of the tubules; 3, damage involving 25% to 50% of
the tubules; and 4, damage in more than 50% of the
tubules.
Immunohistochemical analysis
Kidney sections (4 μm) were deparaffinized with xylene
and rehydrated with decreasing percentages of ethanol
and finally with water. Antigen retrieval was accom-
plished by microwaving the slides in citrate buffer (pH
6.0, Thermo Scientific, AP-9003-500) for 10 min. The
slides were left to cool for 20 min at room temperature
and then rinsed with distilled water. The endogenous
peroxidase activity was blocked with 3% H2O2 for 10
min at room temperature, and the slides were later
rinsed with distilled water and phosphate-buffered sa-
line (PBS). Blocking reagent (Lab Vision, TA-125-UB)
was applied to each slide followed by 10 min of incuba-
tion at room temperature in a humid chamber. Kidney
sections were incubated overnight at 4 °C with rabbit
polyclonal endothelial nitric oxide synthase (eNOS,
1:100) and inducible nitric oxide synthase (iNOS,
1:100) antibodies (eNOS NeoMarkers; Ab iNOS Ab-1,
Rabbit PAb, RB-1605-P, NeoMarkers Fremont, CA,
USA), anti-tumor necrosis factor (TNF)-α (1:200)
(rabbit polyclonal, Abcam ab66579, Abcam Cambridge,
UK), and anti-interleukin (IL)-6 (1:200) antibodies
(rabbit polyclonal, Abcam 6672, Abcam Cambridge,
UK) and incubated for 1 h at room temperature with
anti-myeloperoxidase (MPO) antibody (MPO rabbit
RB-373-A, NeoMarkers Fremont, CA, USA) and anti-
lipocalin-2 (NGAL) antibody (Abcam 41105, Abcam
Cambridge, UK). The sections were washed in PBS
three times for 5 min each time and then incubated for
30 min at room temperature with biotinylated goat
anti-rabbit antibodies (LabVision, TP-125-BN). After
the slides were washed in PBS, the streptavidin peroxid-
ase label reagent (LabVision, TS-125-HR) was applied
for 30 min at room temperature in a humid chamber.
The colored product was developed by incubation with
AEC. The slides were counterstained with Mayer’s
hematoxylin (LabVision, TA-125-MH) and mounted in
vision mount (LabVision, TA-060-UG) after being
washed in distilled water. Both the intensities and dis-
tributions of iNOS and eNOS staining were scored. For
each sample, a histological score (HSCORE) was de-
rived by summing the percentage of cells that were
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stained at each intensity multiplied by the weighted in-
tensity of the staining—HSCORE = S Pi (i + 1), where i
is the intensity score, and Pi is the corresponding per-
centage of cells. The kidney sections were photo-
graphed using a Leica Qwin microscope.
As the measurement of cortical oxygenation and
hemodynamic parameters were performed during the
experiment, investigators were not blinded. However,
creatinine levels, lactate and liver enzymes, and histo-
logical analysis were performed blinded.
Statistical analysis
The results are expressed as the mean ± SEM. A nor-
mality test (D’Agostino test) was performed and, if data
did not follow a gaussian distribution, a non-
parametric test was used (Kruskal-Wallis test with a
Dunn’s post hoc test). If data follow a gaussian distri-
bution, statistical significance was calculated by one-
and two-way analyses of variance (ANOVA) followed
by Bonferroni post tests using GraphPad Prism
(GraphPad Prism, Version 5, Software Program, San
Diego, CA, USA). A p value <0.05 was considered sta-
tistically significant.
Results
Effect of fluid resuscitation and blood transfusion on
systemic and renal hemodynamic parameters during sepsis
The MAP, renal blood flow and renal vascular resistance
are provided in Table 1. Infusion of LPS induced early
and persistent decreases in MAP and renal blood flow.
FR significantly improved the MAP at T2 and T3 and
the renal blood flow at T2. Similarly, BT significantly im-
proved the MAP at T2 and T3 and the renal blood flow
at T2. At the end of the experiment, there were no sig-
nificant differences in terms of the systemic or renal
hemodynamic parameters between the groups that re-
ceived FR or BT after LPS infusion.
Effects of fluid resuscitation and blood transfusion on
renal microvascular oxygenation during sepsis
The CμPO2, rvPO2, DO2ren, and VO2ren values are illus-
trated in Fig. 2. LPS induced significant decreases in
CμPO2 and rvPO2 from baseline to T3 (23.9 ± 8.9
mmHg in the LPS group versus 57.2 ± 2.9 mmHg in the
control group at T3, p < 0.001, and 28.3 ± 3.9 mmHg in
the LPS group versus 58.4 ± 9.7 mmHg in the control
group at T3, respectively, p < 0.01). FR significantly im-
proved the CμPO2 at T2 (54.5 ± 5.8 mmHg versus 35.4
Table 1 Hemodynamic parameters
Baseline (T0) T1 T2 T3
Mean arterial pressure (mmHg)
Control 91.5 ± 4.2 93 ± 4.1 94 ± 4.8 76.1 ± 2.3
LPS 88.7 ± 1.3 49 ± 5.1## 54.9 ± 6.2## 42.2 ± 4.4###
LPS + FR 90.8 ± 1.3 53.5 ± 3.2## 82.7 ± 2.1* 56.6 ± 2.1*,##
LPS + BT 89.5 ± 2.2 54.1 ± 1.7## 86.8 ± 1.7* 61.1 ± 3.2*
Heart rate (beats per minute)
Control 232.9 ± 8.5 247.7 ± 7.7 248 ± 6.4 249.9 ± 13.4
LPS 236.3 ± 11.9 225.6 ± 5.2 226.9 ± 5.9 221 ± 8.5
LPS + FR 227.9 ± 8.7 219 ± 5.1 259 ± 7.7 258 ± 4.3
LPS + BT 255.3 ± 7.7 252.1 ± 5.6 258 ± 5.3 254.6 ± 6.5
Renal blood flow (ml/min)
Control 7.5 ± 0.8 5.1 ± 0.2 5.2 ± 0.3 4.3 ± 0.2
LPS 7.1 ± 0.5 0.8 ± 0.3# 0.9 ± 0.3### 0.6 ± 0.3###
LPS + FR 6.3 ± 0.2 0.4 ± 0.1## 5.4 ± 0.9** 1.6 ± 0.3#
LPS + BT 6.6 ± 0.7 0.8 ± 0.3# 3.2 ± 0.4* 1.8 ± 0.3#
Renal vascular resistances (dynes·s·cm–5)
Control 1291.9 ± 128.2 1823.2 ± 88.2 1844.4 ± 155.9 1784.3 ± 96.4
LPS 1275.2 ± 77.6 17,820 ± 7905.5 18,631.9 ± 11,394.9 20,237.7 ± 7939.2
LPS + FR 1449.9 ± 61.8 18,860.5 ± 6758.4 1853.3 ± 336.2 4390.5 ± 920.3
LPS + BT 1431.3 ± 124.1 12,133.9 ± 3493.6 2919.9 ± 388.8 4860.7 ± 1828.1
Hemodynamic parameters at four time points T0 (baseline), T1, T2, and T3 in the four groups. The data are expressed as the means ± SEMs. See Fig. 1 for definitions of
the time points
#P < 0.05, ##P < 0.01, ###P < 0.001 versus control; *P <0.05, **P < 0.01, versus LPS
BT blood transfusion, FR fluid resuscitation, LPS lipopolysaccharide
Zafrani et al. Critical Care  (2016) 20:406 Page 4 of 10
± 8.8 mmHg in the LPS group, p < 0.05), but this value
began to decrease from T2 to T3 (38.9 ± 2.8 mmHg in
the FR group at T3). BT significantly improved the
CμPO2 at T2 (60.1.5 ± 4.9 mmHg, p < 0.01 versus the
LPS group) and T3 (52.9 ± 6.9 mmHg versus 23.9 ± 8.9
mmHg in the LPS group, p < 0.01). There was a signifi-
cant difference in the CμPO2 values at T3 between the
LPS + FR group and the LPS + BT group (p < 0.05;
Fig. 2a). BT improved the rvPO2 (58.9 ± 13.3 mmHg
versus 28.3 ± 3.9 mmHg in the LPS group, p < 0.01).
The increase in rvPO2 induced by BT was significantly
greater than the increase in rvPO2 that was induced by
FR (p < 0.05; Fig. 2b). The DO2ren was significantly de-
creased after LPS and was partially restored at T3 in
the BT group (p < 0.05 at T3 versus LPS). Differences
between DO2ren in the BT group and the FR group at
T3 did not reach statistical significance (Fig. 2c). There
was a significant drop in VO2ren in the LPS group com-
pared to the controls (p < 0.01). FR and BT both re-
stored the VO2ren at T3 (p < 0.001 and p < 0.01,
respectively, at T3).
Effects of fluid resuscitation and blood transfusion on
hemoglobin, pH, serum lactate, and liver function
The hemoglobin levels, pH, serum lactate levels, and liver
enzymes are illustrated in Fig. 3. As expected, FR induced
significant decreases in hemoglobin values due to hemodi-
lution (Fig. 3a). LPS infusion induced a significant drop in
pH at T3 (p < 0.01 versus the control group) that was par-
tially restored by FR and BT without any significant differ-
ence between the two groups (Fig. 3b). The serum lactate
levels increased during sepsis (p < 0.01 at T2 and p < 0.05
at T3 in the LPS group versus the control group), but nei-
ther FR nor BT completely restored these values (Fig. 3c).
Moreover, neither FR nor BT improved the LPS-induced
increase in aspartate aminotransferase (AST), which is a
surrogate marker for liver damage (Fig. 3d).
Effects of fluid resuscitation and blood transfusion on
renal function, metabolic cost, and tubular lesions during
sepsis
The creatinine levels are illustrated in Fig. 4a. At T1, all
of the LPS-treated animals were anuric. This condition
Fig. 2 Renal oxygenation parameters. a Evolution of microvascular oxygen tension in the renal cortex (CμPO2) in the four groups at baseline (T0),
T1, T2, and T3. b Renal venous partial pressure of oxygen (PO2) at T3 in the four groups. c Evolution of renal oxygen delivery (DO2ren) in the four
groups at T0, T1, T2, and T3. d Renal oxygen consumption (VO2ren) at T3 in the four groups.
##P < 0.01, ###P < 0.001, versus control; *P < 0.05,
**P < 0.01, ***P < 0.001, versus LPS; †P <0.05, versus LPS + FR. The values are shown as mean ± SEM. See Fig.1 for definitions of the time points. BT
blood transfusion, FR fluid resuscitation, LPS lipopolysaccharide
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did not improve in the non-resuscitation group. All rats
that received LPS suffered from AKI as reflected by in-
creased plasmatic creatinine levels, and FR was not able
to prevent AKI. The plasma creatinine levels did not dif-
fer significantly between the LPS group and the LPS +
FR group. However, BT significantly decreased the
plasma creatinine levels (39.6 ± 7.4 μmol/l in the LPS +
BT group versus 77.7 ± 8.9 μmol/l in the LPS group at
T3, p < 0.01, and 64 ± 7.2 μmol/l in the LPS + FR group,
p < 0.05). Similarly, creatinine clearance significantly im-
proved at T3 in the LPS + BT group (p < 0.05 versus LPS
+ FR group) (Fig. 4b).
The metabolic cost of sodium reabsorption as assessed
with the VO2/TNa
+ could not be calculated in the LPS
group due to the absence of urine output after LPS ad-
ministration without resuscitation. However, whereas
LPS + FR induced an increase in VO2/TNa
+ (p < 0.05
compared to the controls), the VO2/TNa
+ ratio was not
different after LPS + BT compared with the controls (p <
0.05 versus the FR group; Fig. 4c).
LPS induced tubular damage, including tubular vacuo-
lization, tubular invagination, brush border loss, and lu-
minal cast formation. BT, but not FR, significantly
improved the tubular damage (mean histological score
of 3 ± 0.06 in the LPS + BT group versus 3.4 ± 0.06 in the
LPS group, p < 0.01, and 3.3 ± 0.06 in the LPS + FR
group, p < 0.05; Fig. 5a and b).
Effects of fluid resuscitation and blood transfusion on
renal iNOS, eNOS expression, and tissue inflammatory
markers
The renal expression of eNOS was markedly suppressed
under endotoxin challenge (p < 0.001; Fig. 5c). BT signifi-
cantly increased eNOS expression after LPS (mean H-
score of 243 ± 4 in the LPS + BT group versus 192.3 ± 1.5
in the LPS group, p < 0.001). The renal expression of
eNOS did not increase after FR (mean H-score of 190.4
± 2.6). In contrast, the renal expression of iNOS was
markedly increased under endotoxin challenge (p < 0.01;
Fig. 5d). Whereas FR decreased iNOS expression after
LPS (p < 0.01 in the LPS + FR group compared to the
LPS group), BT did not change iNOS expression after
LPS.
Neutrophil gelatinase-associated lipocalin (NGAL), a
marker of AKI and kidney inflammation, significantly
improved after BT compared to the LPS group (p <
0.05). However, the immunostaining intensity of NGAL
was not statistically different between the LPS + FR and
Fig. 3 Hemoglobin, pH, serum lactate, and liver function during septic shock and resuscitation. a Hemoglobin concentrations at T0, T1, T2, and
T3 in the four groups. b pH at T3 in the four groups. c Serum lactate levels at T2 and T3 in the four groups. d Aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) levels at T3 in the four groups. #P < 0.05, ##P < 0.01, versus control; *P < 0.05, **P < 0.01, versus LPS; †††P <0.001,
versus LPS + FR. The values are shown as mean ± SEM. See Fig.1 for definitions of the time points. BT blood transfusion, FR fluid resuscitation,
LPS lipopolysaccharide
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LPS + BT groups (Additional file 1: Figure S1). Sepsis in-
duced an increase in pro-inflammatory cytokines (TNF-
α and IL-6) into the kidney, but there was no statistical
difference between the LPS + FR and LPS + BT groups
(Additional file 1: Figure S2). Similarly, MPO activity
within the kidney, a marker of oxidative stress, was not
different between the two groups (Additional file 1: Fig-
ure S1).
Discussion
In the present study, we demonstrated that BT restored
renal microcirculatory oxygenation and, by extension,
kidney function in a rat model of endotoxemia. BT had
beneficial effects on kidney microvascular oxygenation,
metabolic costs, and AKI. Sepsis-induced eNOS defi-
ciency and renal damage were corrected by BT but not
by FR.
Johannes et al. previously demonstrated the appear-
ance of cortical microcirculatory hypoxic areas in
endotoxin-induced renal failure in the rat [3]. In the
present study, we confirmed the drop in renal cortical
oxygenation induced by LPS. A part of this anoxia was
due to the drop of the renal blood flow during septic
shock. Indeed, FR was only able to temporarily improve
cortical oxygenation by improving the renal blood flow.
However, BT had stronger and longer-lasting effects on
renal microvascular oxygenation despite similar renal
blood flows. Microcirculatory dysfunction may contrib-
ute to renal hypoxia even in the absence of frank renal
hypoperfusion. Several studies using microcirculatory
techniques have now questioned the significance of ar-
terial renal blood flow [15] and have suggested that the
renal microcirculation is the hemodynamic culprit in the
pathophysiology of septic AKI [16]. The microcirculation
of the renal cortex has been demonstrated to be severely
injured in animal models of sepsis [3, 5]. Legrand et al.
demonstrated that the prevention of renal macrovascular
hypoperfusion by FR cannot fully prevent renal microcir-
culatory oxygenation and perfusion dysfunction after
LPS infusion in rats, despite a normalized renal blood
flow [5]. Severe sepsis is characterized by a reduction in
functional capillary density and an increase in blood flow
heterogeneity. Indeed, the ischemic component is not
found in global renal arterial blood flow but rather in a
defect in the distribution of renal cortex microcircula-
tion involving patchy areas of micro-ischemia [5]. Our
study was not designed to demonstrate the distribution
of red blood cells inside the kidneys after BT, and we
cannot rule out the possibility that some areas inside the
kidneys did not receive the oxygen delivered by the
Fig 4 Kidney function and metabolic cost during septic shock and resuscitation. a Serum creatinine (SCr; μmol/l) at T0 and T3 in the four groups.
b Creatinine clearance (ml/mn) at T0 and T3 in the four groups. c VO2/TNa
+ (oxygen consumption per sodium reabsorbed (metabolic cost)) at T3
in the control group, LPS + FR group and LPS + BT group. #P < 0.05, ##P < 0.01, versus control; *P < 0.05, **P < 0.01, versus LPS; †P <0.05, versus LPS + FR.
The values are shown as mean ± SEM. See Fig.1 for definitions of the time points. BT blood transfusion, FR fluid resuscitation, LPS lipopolysaccharide
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erythrocytes. However, the global effect of BT was an
improvement in microvascular oxygenation that was in-
dependent of renal macrovascular perfusion. Moreover,
the VO2/TNa
+, which is a functional index of the effi-
ciency of oxygen utilization for TNa+ and a functional
parameter that reflects tubular injury [17], demonstrated
more efficiency in oxygen utilization for tubular trans-
port following BT than following FR. This improvement
in kidney oxygenation participated in the improvement
in kidney function. Indeed, renal tissue hypoxia is an im-
portant common feature of AKI [18] and is a major
driver of the cascade of events that leads to cellular in-
jury and vascular and tubular dysfunction [19]. In our
study, improvements in kidney oxygenation translated
into better renal outcomes as assessed by the serum cre-
atinine levels and tubular damage.
These effects could be mediated in part by a restor-
ation of eNOS activity after BT. Indeed, in accordance
with previous studies we found a significant decrease in
eNOS expression in the kidney under endotoxin
challenge. In a murine model of cecal ligation and
puncture-induced septic shock, Coletta et al. demon-
strated that the lack of eNOS production alone may be
sufficient to markedly exacerbate the severity of septic
shock [20]. Nitric oxide (NO) is an important mediator
of microvascular patency and blood flow, and strategies
that aim to enhance endothelial eNOS activity have been
found to decrease sepsis-induced neutrophil-endothelial
cell interactions and may play a role in maintaining
microvascular patency in septic shock [21]. Notably,
Souza et al. reported similar findings that increasing
hemoglobin levels using erythropoeitin in septic rats
preserves renal eNOS expression and thereby prevents
sepsis-induced AKI [22]. Thus, we hypothesize that the
specific effect of BT on eNOS expression in the kidney
may have improved the endothelial dysfunction and
renal microcirculation in our model.
However, there are contradictory results from clinical
studies in which BT was administered during sepsis. BT
has been associated with increased mortality in
Fig. 5 Renal histological changes and renal expressions of eNOS and iNOS during septic shock and resuscitation. a Representative periodic acid
Schiff staining in the kidneys of the control, LPS, LPS + FR, and LPS + BT rats (original magnification × 400) and tubular injury scores in the four
groups. Tubular vacuolization images of the LPS and LPS + FR groups further demonstrate the considerable tubular vacuolization (asterisks) as well
as the loss of the brush border in the renal tubule (closed arrows). b Quantification of the tubular injury scores in the kidney sections. c Quantification
of endothelial nitric oxide synthase (eNOS) staining intensities (H-score) in the kidney sections. d Quantification of inducible nitric oxide synthase (iNOS)
staining intensities (H-score) in the kidney sections. The values are shown as mean ± SEM. ###P < 0.001, versus control; **P < 0.01, versus LPS; †P <0.05,
†††P <0.001, versus LPS + FR. BT blood transfusion, FR fluid resuscitation, LPS lipopolysaccharide
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subgroups of critically ill patients in both cohort studies
and randomized trials [23, 24], but there have also been
cohort studies in which transfusion was associated with
improved survival, including in patients with sepsis [25,
26]. In a recent randomized controlled study, Holst et al.
found that mortality rates were similar in patients who
received BT at a higher hemoglobin threshold and those
who received BT at a lower threshold during septic
shock [27]. Our study did not investigate long-term sur-
vival or outcomes. We measured serum lactate as a glo-
bal perfusion biomarker and liver enzymes as markers of
liver function. In accordance with the study of Holst et
al., we did not find any benefit of BT on liver function
or lactic acidosis when compared with FR. How then
can we explain the specific protective effect of BT on
renal function? First, some data suggest a direct influ-
ence of hemodilution on microvascular flow and renal
oxygen supply. The critical hematocrit associated with a
decrease in microvascular PO2 has already been found
to be much higher for the kidney than for the intestines
and the heart [28]. The benefit of increasing the
hematocrit level with BT may therefore be greater for
the kidney than for other organs. Second, there is accu-
mulating evidence that endothelial cell phenotypes vary
between different organs and exhibit remarkable hetero-
geneity in structure and function [29, 30]. Under similar
conditions, eNOS activity is also highly variable between
organs [30, 31]. eNOS is highly expressed in glomerular
endothelial cells and the endothelium of cortical vessels
in control and diseased kidneys [32]. Thus, we
hypothesize that, depending on the level of eNOS activ-
ity and the interaction between BT and endothelial cells,
the influence of BT may vary greatly from one organ to
another.
When studying the effect of BT during sepsis, another
important issue needs to be accounted for: the failure to
identify significant improvements in outcomes in clinical
studies may pertain to the potentially deleterious effect
of blood storage. In our study, we transfused fresh blood
to the septic rats. During storage, erythrocytes are ex-
posed to and produce substances that impair their func-
tion when they are returned to the circulation [33]. In
this situation, BT may, rather than improving oxygen-
ation, worsen oxygen balance and AKI. The use of fresh
blood in our study may therefore, in part, explain the
beneficial effects we observed in terms of renal oxygen-
ation and AKI. However, a recent randomized trial com-
paring transfusion of fresh red cells to standard-issue
red cells did not found any difference in terms of mor-
tality in a large population of critically ill patients [34].
Limitations
Our study has several limitations. First, the acute and le-
thal model of endotoxic shock (in a limited sample size
of animals) used herein is clearly not fully representative
of human septic shock. LPS causes much earlier and
higher peak levels of cytokine expression compared with
levels observed in human sepsis. However, endotoxemic
challenge with LPS remains a useful tool for interrogat-
ing a simpler subset of the complex trajectory of sepsis.
Second, our rats were resuscitated with fluids but not
norepinephrine. The use of norepinephrine has been
shown to be associated with better tissue oxygenation
when compared with fluid resuscitation alone [35, 36].
Finally, the modalities, timing, and threshold of
hemoglobin that need to be targeted have to be defined
before conducting a clinical trial focusing on sepsis-
induced AKI.
Conclusion
In conclusion, BT might be useful as a renal protective
strategy to preserve renal oxygenation and kidney func-
tion during sepsis. However, additional studies are war-
ranted to evaluate the true clinical value of BT in this
setting and its prolonged beneficial effects on kidney
function.
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Immunostaining of tumor necrosis factor alpha (TNF-α) and interleukin-6
(IL-6) in kidney sections in the four groups. #P < 0.05, ###P < 0.001, versus
control; *P < 0.05, versus LPS. (DOCX 103 kb)
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